Involvement of CDX2 in the cross talk between TNF-α and Wnt signaling pathway in the colon cancer cell line Caco-2

Carcinogenesis

Volumn 35, Issue 5, 2014, Pages 1185-1192

  Coskun, Mehmet ^a,b   Olsen, Anders Krüger ^b,c   Bzorek, Michael ^c   Holck, Susanne ^d   Engel, Ulla Højholt ^d   Nielsen, Ole Haagen ^a   Troelsen, Jesper Thorvald ^e  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c NAESTVED HOSPITAL   (Denmark)

^d Mental Health Center Glostrup   (Denmark)

^e ROSKILDE UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AXIS INHIBITION PROTEIN 2; BETA CATENIN; GLYCOGEN SYNTHASE KINASE 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MEMBRANE PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; TRANSCRIPTION FACTOR CDX2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CACO 2 CELL LINE; CANCER CELL CULTURE; COLON CANCER; COLON POLYPOSIS; CONTROLLED STUDY; DOWN REGULATION; ENHANCER REGION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; INFLAMMATORY CELL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROMOTER REGION; SIGNAL TRANSDUCTION; TUMOR PROMOTION; WNT SIGNALING PATHWAY;

BETA CATENIN; CACO-2 CELLS; COLONIC NEOPLASMS; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MAP KINASE SIGNALING SYSTEM; NF-KAPPA B; PROTEIN BINDING; TUMOR NECROSIS FACTOR-ALPHA; WNT SIGNALING PATHWAY;

EID: 84902012810     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgu037     Document Type: Article

References (64)

1. Herr, P. et al. (2012) WNT secretion and signalling in human disease. Trends Mol. Med., 18, 483-493.
2. White, B.D. et al. (2012) Dysregulation of Wnt/ß-catenin signaling in gastrointestinal cancers. Gastroenterology, 142, 219-232.
3. Ordás, I. et al. (2012) Ulcerative colitis. Lancet, 380, 1606-1619.
4. Baumgart, D.C. et al. (2012) Crohn's disease. Lancet, 380, 1590-1605.
5. Eaden, J.A. et al. (2001) The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut, 48, 526-535.
6. Jess, T. et al. (2005) Increased risk of intestinal cancer in Crohn's disease: a meta-analysis of population-based cohort studies. Am. J. Gastroenterol., 100, 2724-2729.
7. Ullman, T.A. et al. (2011) Intestinal inflammation and cancer. Gastroenterology, 140, 1807-1816.
8. Jess, T. et al. (2012) Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years. Gastroenterology, 143, 375-81. e1; quiz e13.
9. Jass, J.R. et al. (1987) A new prognostic classification of rectal cancer. Lancet, 1, 1303-1306.
10. Pollard, J.W. (2004) Tumour-educated macrophages promote tumour progression and metastasis. Nat. Rev. Cancer, 4, 71-78.
11. Etoh, T. et al. (2000) Angiogenin expression in human colorectal cancer: the role of focal macrophage infiltration. Clin. Cancer Res., 6, 3545-3551.
12. Cox, G.W. et al. (1992) Tumor necrosis factor-alpha-dependent production of reactive nitrogen intermediates mediates IFN-gamma plus IL-2-induced murine macrophage tumoricidal activity. J. Immunol., 149, 3290-3296.
13. Breese, E.J. et al. (1994) Tumor necrosis factor alpha-producing cells in the intestinal mucosa of children with inflammatory bowel disease. Gastroenterology, 106, 1455-1466.
14. Deng, L. et al. (2010) A novel mouse model of inflammatory bowel disease links mammalian target of rapamycin-dependent hyperproliferation of colonic epithelium to inflammation-associated tumorigenesis. Am. J. Pathol., 176, 952-967.
15. Balkwill, F. (2006) TNF-alpha in promotion and progression of cancer. Cancer Metastasis Rev., 25, 409-416.
16. Sethi, G. et al. (2008) TNF: a master switch for inflammation to cancer. Front. Biosci., 13, 5094-5107.
17. Bates, R.C. et al. (2003) Tumor necrosis factor-alpha stimulates the epithelial-to-mesenchymal transition of human colonic organoids. Mol. Biol. Cell, 14, 1790-1800.
18. Szlosarek, P. et al. (2006) Tumour necrosis factor-alpha as a tumour promoter. Eur. J. Cancer, 42, 745-750.
19. Boyd, M. et al. (2010) Genome-wide analysis of CDX2 binding in intestinal epithelial cells (Caco-2). J. Biol. Chem., 285, 25115-25125.
20. Olsen, A.K. et al. (2012) Current and emerging approaches to define intestinal epithelium-specific transcriptional networks. Am. J. Physiol. Gastrointest. Liver Physiol., 302, G277-G286.
21. Verzi, M.P. et al. (2010) Differentiation-specific histone modifications reveal dynamic chromatin interactions and partners for the intestinal transcription factor CDX2. Dev. Cell, 19, 713-726.
22. Crissey, M.A. et al. (2011) Cdx2 levels modulate intestinal epithelium maturity and Paneth cell development. Gastroenterology, 140, 517-528.e8.
23. Gao, N. et al. (2009) Establishment of intestinal identity and epithelialmesenchymal signaling by Cdx2. Dev. Cell, 16, 588-599.
24. Brabletz, T. et al. (2004) Down-regulation of the homeodomain factor Cdx2 in colorectal cancer by collagen type I: an active role for the tumor environment in malignant tumor progression. Cancer Res., 64, 6973-6977.
25. Gross, I. et al. (2008) The intestine-specific homeobox gene Cdx2 decreases mobility and antagonizes dissemination of colon cancer cells. Oncogene, 27, 107-115.
26. Subtil, C. et al. (2007) Frequent rearrangements and amplification of the CDX2 homeobox gene in human sporadic colorectal cancers with chromosomal instability. Cancer Lett., 247, 197-203.
27. Laurent, C. et al. (2011) Immunohistochemical expression of CDX2, ß-catenin, and TP53 in inflammatory bowel disease-associated colorectal cancer. Inflamm. Bowel Dis., 17, 232-240.
28. Hinkel, I. et al. (2012) Cdx2 controls expression of the protocadherin Mucdhl, an inhibitor of growth and ß-catenin activity in colon cancer cells. Gastroenterology, 142, 875-885.e3.
29. Guo, R.J. et al. (2010) The intestine-specific transcription factor Cdx2 inhibits beta-catenin/TCF transcriptional activity by disrupting the betacatenin-TCF protein complex. Carcinogenesis, 31, 159-166.
30. Clevers, H. (2006) Wnt/beta-catenin signaling in development and disease. Cell, 127, 469-480.
31. Gregorieff, A. et al. (2005) Expression pattern of Wnt signaling components in the adult intestine. Gastroenterology, 129, 626-638.
32. Olsen, A.K. et al. (2013) Regulation of APC and AXIN2 expression by intestinal tumor suppressor CDX2 in colon cancer cells. Carcinogenesis, 34, 1361-1369.
33. Kimelman, D. et al. (2006) Beta-catenin destruction complex: insights and questions from a structural perspective. Oncogene, 25, 7482-7491.
34. Barros, R. et al. (2011) CDX2 autoregulation in human intestinal metaplasia of the stomach: impact on the stability of the phenotype. Gut, 60, 290-298.
35. Boyd, M. et al. (2009) Mapping of HNF4alpha target genes in intestinal epithelial cells. BMC Gastroenterol., 9, 68.
36. Coskun, M. et al. (2011) MAP kinases in inflammatory bowel disease. Clin. Chim. Acta., 412, 513-520.
37. Lemieux, E. et al. (2011) Constitutive activation of the MEK/ERK pathway inhibits intestinal epithelial cell differentiation. Am. J. Physiol. Gastrointest. Liver Physiol., 301, G719-G730.
38. Rings, E.H. et al. (2001) Phosphorylation of the serine 60 residue within the Cdx2 activation domain mediates its transactivation capacity. Gastroenterology, 121, 1437-1450.
39. Krueger, F. et al. (2009) Down-regulation of Cdx2 in colorectal carcinoma cells by the Raf-MEK-ERK 1/2 pathway. Cell. Signal., 21, 1846-1856.
40. Houde, M. et al. (2001) Intestinal epithelial cell differentiation involves activation of p38 mitogen-activated protein kinase that regulates the homeobox transcription factor CDX2. J. Biol. Chem., 276, 21885-21894.
41. Kim, S. et al. (2002) PTEN and TNF-alpha regulation of the intestinal-specific Cdx-2 homeobox gene through a PI3K, PKB/Akt, and NF-kappaBdependent pathway. Gastroenterology, 123, 1163-1178.
42. Coskun, M. et al. (2012) TNF-a-induced down-regulation of CDX2 suppresses MEP1A expression in colitis. Biochim. Biophys. Acta, 1822, 843-851.
43. McMillan, D.C. et al. (2007) Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer. Int. J. Colorectal Dis., 22, 881-886.
44. Coskun, M. et al. (2010) Control of intestinal promoter activity of the cellular migratory regulator gene ELMO3 by CDX2 and SP1. J. Cell. Biochem., 109, 1118-1128.
45. Dydensborg, A.B. et al. (2006) Normalizing genes for quantitative RT-PCR in differentiating human intestinal epithelial cells and adenocarcinomas of the colon. Am. J. Physiol. Gastrointest. Liver Physiol., 290, G1067-G1074.
46. Frank, S.R. et al. (2001) Binding of c-Myc to chromatin mediates mitogeninduced acetylation of histone H4 and gene activation. Genes Dev., 15, 2069-2082.
47. Schneikert, J. et al. (2007) The canonical Wnt signalling pathway and its APC partner in colon cancer development. Gut, 56, 417-425.
48. Oguma, K. et al. (2008) Activated macrophages promote Wnt signalling through tumour necrosis factor-alpha in gastric tumour cells. EMBO J., 27, 1671-1681.
49. Ueno, H. et al. (2002) Tumour 'budding' as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology, 40, 127-132.
50. Hanahan, D. et al. (2011) Hallmarks of cancer: the next generation. Cell, 144, 646-674.
51. Qian, B.Z. et al. (2010) Macrophage diversity enhances tumor progression and metastasis. Cell, 141, 39-51.
52. Waldner, M.J. et al. (2012) Interleukin-6-a key regulator of colorectal cancer development. Int. J. Biol. Sci., 8, 1248-1253.
53. Popivanova, B.K. et al. (2008) Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. J. Clin. Invest., 118, 560-570.
54. Greten, F.R. et al. (2004) IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell, 118, 285-296.
55. Wang, S. et al. (2009) NF-kappaB signaling pathway, inflammation and colorectal cancer. Cell. Mol. Immunol., 6, 327-334.
56. Schwitalla, S. et al. (2013) Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties. Cell, 152, 25-38.
57. Blache, P. et al. (2004) SOX9 is an intestine crypt transcription factor, is regulated by the Wnt pathway, and represses the CDX2 and MUC2 genes. J. Cell Biol., 166, 37-47.
58. Tetsu, O. et al. (1999) Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature, 398, 422-426.
59. He, T.C. et al. (1998) Identification of c-MYC as a target of the APC pathway. Science, 281, 1509-1512.
60. Li, Y. et al. (2011) HEF1, a novel target of Wnt signaling, promotes colonic cell migration and cancer progression. Oncogene, 30, 2633-2643.
61. Koch, S. et al. (2012) The life and death of epithelia during inflammation: lessons learned from the gut. Annu. Rev. Pathol., 7, 35-60.
62. Zheng, X. et al. (2011) Suppression of hath1 gene expression directly regulated by hes1 via notch signaling is associated with goblet cell depletion in ulcerative colitis. Inflamm. Bowel Dis., 17, 2251-2260.
63. Verzi, M.P. et al. (2011) Essential and redundant functions of caudal family proteins in activating adult intestinal genes. Mol. Cell. Biol., 31, 2026-2039.
64. Verzi, M.P. et al. (2013) Intestinal master transcription factor CDX2 controls chromatin access for partner transcription factor binding. Mol. Cell. Biol., 33, 281-292.